METTL14‐Mediated RPL13A Expression Regulates Apoptosis and Invasion of Osteosarcoma via the PTEN/PI3K/AKT Signaling Pathway
Journal of Orthopaedic Research · 2026-06 · 44 (6)
DOI: 10.1002/jor.70232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 02.06.2026. Verfasst von Zilong Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Osteosarcoma, Methyltransferases, PTEN Phosphohydrolase, Ribosomal Proteins. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Inner Mongolia Autonomous Region, Natural Science Foundation of Inner Mongolia.
Abstract (Originalsprache)
Osteosarcoma (OS) is a highly aggressive mesenchymal bone tumor with a dismal prognosis, and its underlying molecular mechanisms remain elusive. Ribosomal protein L13a (RPL13a) contributes to tumorigenesis, while methyltransferase‐like 14 (METTL14), a core m 6 A methyltransferase, modulates OS progression via epigenetic regulation. Our prior work identified the PTEN/PI3K/AKT pathway as a key OS regulator. This study aimed to clarify the regulatory interplay among METTL14, RPL13a and PTEN/PI3K/AKT in OS, and verify that METTL14 mediates RPL13a m 6 A modification to regulate PTEN/PI3K/AKT signaling, affecting OS cell proliferation, apoptosis, migration and invasion. METTL14, RPL13a and m 6 A levels were detected in OS cell lines (U2OS, HOS, MG‐63) and normal osteoblast hFOB1.19 cells. RPL13a knockdown, PTEN overexpression and METTL14 overexpression models were established in U2OS/HOS cells. M 6 A‐RIP‐qPCR and MeRIP assays confirmed RPL13a m 6 A modification, with functional (CCK‐8, flow cytometry, wound healing, Transwell) and molecular (RT‐qPCR, Western blotting) assays performed in triplicate replicates. METTL14 and RPL13a were upregulated in U2OS/HOS cells versus hFOB1.19 ( p < 0.05). METTL14 overexpression elevated RPL13a m 6 A modification by ~1.8‐fold ( p < 0.05); si‐RPL13a reduced RPL13a mRNA by > 60% ( p < 0.05). RPL13a knockdown promoted apoptosis, inhibited proliferation/migration/invasion, downregulated PTEN and activated PI3K/AKT signaling, partially reversed by PTEN overexpression. METTL14 overexpression upregulated RPL13a/PTEN and suppressed PI3K/AKT activation, abolished by RPL13a knockdown. METTL14 appears to mediate the m6A methylation modification of RPL13a mRNA. Downregulation of RPL13a is associated with reduced PTEN and activated PTEN/PI3K/AKT signaling, which may ultimately contribute to suppressed osteosarcoma cell proliferation, migration, and invasion while promoting apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inner Mongolia Medical University, Hohhot, China.
- The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
ORCID-Profile: Wei Feng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Inner Mongolia Autonomous Region
- Natural Science Foundation of Inner Mongolia
Zitieren
APA
Chen, Z., Pan, Y., Wei, Y., Tong, Y., Li, Y., Zhao, G., Xue, F., Zhao, Y., Meng, C., & Feng, W. (2026). METTL14‐Mediated RPL13A Expression Regulates Apoptosis and Invasion of Osteosarcoma via the PTEN/PI3K/AKT Signaling Pathway. Journal of Orthopaedic Research, 44(6). https://doi.org/10.1002/jor.70232
Vancouver
Chen Z, Pan Y, Wei Y, Tong Y, Li Y, Zhao G, et al. METTL14‐Mediated RPL13A Expression Regulates Apoptosis and Invasion of Osteosarcoma via the PTEN/PI3K/AKT Signaling Pathway. Journal of Orthopaedic Research. 2026;44(6). doi:10.1002/jor.70232
BibTeX
@article{Chen2026,
author = {Chen, Zilong and Pan, Yanqi and Wei, Yuhang and Tong, Yanxiang and Li, Yaguang and Zhao, Guozhong and Xue, Fei and Zhao, Yanhui and Meng, Chenyang and Feng, Wei},
title = {METTL14‐Mediated RPL13A Expression Regulates Apoptosis and Invasion of Osteosarcoma via the PTEN/PI3K/AKT Signaling Pathway},
journal = {Journal of Orthopaedic Research},
year = {2026},
volume = {44},
number = {6},
doi = {10.1002/jor.70232}
}
EUVIMED